ADAMTS9 and ovarian cancer: Thus, lncRNA ADAMTS9-AS1 can attenuate ferroptosis by targeting the miR-587/SLC7A11 axis in ovarian cancer cell lines, thereby providing a new therapeutic target for the treatment of these patients [120].